Skip to main content

Gonococcal Infection - Disseminated News

CDC Supports Use of Doxycycline as 'Morning After Pill' to Stop STDs

WEDNESDAY, June 5, 2024 – In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to lower the risk of...

CDC Supports Use of Doxycycline as 'Morning After Pill' to Stop STDs

WEDNESDAY, June 5, 2024 – In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to lower the risk of...

CDC Supports Use of Doxycycline as 'Morning After Pill' to Stop STDs

WEDNESDAY, June 5, 2024 – In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to lower the risk of...

Rise in Drug-Resistant Gonorrhea in China May Pose Global Threat

THURSDAY, March 28, 2024 – Cases of a strain of highly antibiotic-resistant gonorrhea that first emerged in China in 2016 have tripled there in just five years, according to research published in...

Cases of Drug-Resistant Gonorrhea Have Tripled in China, Posing a Global Threat

THURSDAY, March 28, 2024 – A strain of highly antibiotic-resistant gonorrhea first emerged in China in 2016, and cases of this tough-to-treat infection have tripled there in just five years, Chinese...

First OTC Test for Chlamydia, Gonorrhea Approved by the FDA

THURSDAY, Nov. 16, 2023 – On Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and...

Drug-Resistant Gonorrhea May Get A New Antibiotic

FRIDAY, Nov. 3, 2023 – The first new antibiotic for gonorrhea – the second most common sexually transmitted disease – has shown promise in a clinical trial. This new antibiotic, called...

New Antibiotic, Zoliflodacin, Seeking Approval, Tackles Drug-Resistant Gonorrhea in Trial

FRIDAY, Nov. 3, 2023 – The first new antibiotic for gonorrhea — the second most common sexually transmitted disease — has shown promise in a clinical trial. That news should come as a relief to pub...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

Cipro, ciprofloxacin, Levaquin, levofloxacin, Rocephin